JW Asset Management

Tyson 2.0 is a cannabis company founded by the renowned boxer and entrepreneur Mike Tyson. The company specializes in producing a diverse range of cannabis products, including full-spectrum cannabis flowers, concentrates, and consumables. With a commitment to purity and precision, Tyson 2.0 aims to provide consumers with high-quality products that are both premium and affordable. These offerings are widely accessible at retailers across the nation, ensuring that a broad audience can enjoy their products.

Allumia, LLC specializes in energy efficiency solutions, focusing on lighting upgrades for commercial, athletic, automotive, and industrial sectors. Founded in 2013 and headquartered in Seattle, Washington, with additional offices in Los Angeles and Durham, the company designs, funds, installs, and manages lighting projects. Allumia evaluates existing lighting systems and provides tailored proposals that include updated designs and anticipated savings. The company also supplies replacement lamps, drivers, and other lighting hardware, along with ongoing maintenance services. Utilizing a software and Internet of Things platform, Allumia streamlines the financing and management of energy efficiency projects, enabling clients to achieve complete equipment upgrades at reduced costs while maximizing energy savings. The company serves customers directly and collaborates with utility partners to enhance the efficiency of their operations across the nation.

Pistil Data is a prominent market intelligence company specializing in the consumer packaged goods (CPG) sector, particularly within the cannabis industry. The company has developed a comprehensive platform that provides detailed insights into every brand and product in the cannabis market. This platform allows users to identify retail opportunities, track significant market changes, and discover strategies to enhance shelf space for cannabis products. By offering customized sales opportunities and access to crucial data, Pistil Data enables cannabis brands to effectively grow their sales and expand their market presence.

Semasio GmbH, founded in 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to provide a platform that helps marketers build detailed user profiles and identify target groups. Semasio's offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, utilizing Natural Language Processing to analyze website content and create comprehensive profiles for both websites and users. This enables clients, including global agency networks and advertisers, to strategically address specific audiences and optimize their advertising efforts. Additionally, Semasio's technology allows for precise control over the contextual placements of online advertising content, ensuring relevance and efficiency. With development centers in Denmark and Portugal, Semasio is dedicated to enhancing the effectiveness of programmatic advertising in a privacy-conscious environment.

CityRow Holdings, Inc. specializes in health and fitness services, offering a unique blend of workouts that include yoga, strength training, and cardio, primarily utilizing water-based rowing machines. Founded in 2014 and headquartered in New York City, the company operates three locations in Michigan and New York. CityRow also provides a digital platform, Cityrow Go, which is a rowing-based fitness app designed for smartphones and tablets. This app features a variety of rowing classes aimed at delivering effective and motivating workouts for users at home. The studio's approach focuses on enhancing aerobic capacity and overall body efficiency through high-intensity interval training that emphasizes low-impact exercises, helping individuals achieve their fitness goals in a scientifically guided manner.

Semasio GmbH, founded in 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to provide a platform that helps marketers build detailed user profiles and identify target groups. Semasio's offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, utilizing Natural Language Processing to analyze website content and create comprehensive profiles for both websites and users. This enables clients, including global agency networks and advertisers, to strategically address specific audiences and optimize their advertising efforts. Additionally, Semasio's technology allows for precise control over the contextual placements of online advertising content, ensuring relevance and efficiency. With development centers in Denmark and Portugal, Semasio is dedicated to enhancing the effectiveness of programmatic advertising in a privacy-conscious environment.

Gage Cannabis Co. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market.

Semasio GmbH, founded in 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to provide a platform that helps marketers build detailed user profiles and identify target groups. Semasio's offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, utilizing Natural Language Processing to analyze website content and create comprehensive profiles for both websites and users. This enables clients, including global agency networks and advertisers, to strategically address specific audiences and optimize their advertising efforts. Additionally, Semasio's technology allows for precise control over the contextual placements of online advertising content, ensuring relevance and efficiency. With development centers in Denmark and Portugal, Semasio is dedicated to enhancing the effectiveness of programmatic advertising in a privacy-conscious environment.

High 12 is a consumer packaged goods company based in Toronto, Canada, established in 2018. The company specializes in the cannabis sector, focusing on the development and operation of prominent global cannabis brands. High 12 emphasizes a consumer-centric approach to product creation and launch, utilizing data-driven analysis to ensure the success and recognition of its brands. By building strong brand identities, High 12 aims to foster a sense of community and connection among users, highlighting the shared social fabric associated with cannabis consumption. Additionally, the company seeks to develop strategic supply-chain partnerships to enhance its operational efficiency and brand offerings.

Canndescent LLC is a cannabis company based in Santa Barbara, California, specializing in the cultivation of premium cannabis flowers. The company adheres to state and local regulations, ensuring compliance in all aspects of its operations. Canndescent employs a proprietary cultivation technology that enhances the aromas and flavors of its products, focusing on quality management and deep cultivation expertise. By abandoning traditional strain names, Canndescent aims to simplify the customer experience, allowing consumers to access cannabis flowers that are produced, packaged, and distributed in a consistent manner. The company caters to both recreational and medical markets, emphasizing the transformative potential of its cannabis offerings.

Semasio GmbH, founded in 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to provide a platform that helps marketers build detailed user profiles and identify target groups. Semasio's offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, utilizing Natural Language Processing to analyze website content and create comprehensive profiles for both websites and users. This enables clients, including global agency networks and advertisers, to strategically address specific audiences and optimize their advertising efforts. Additionally, Semasio's technology allows for precise control over the contextual placements of online advertising content, ensuring relevance and efficiency. With development centers in Denmark and Portugal, Semasio is dedicated to enhancing the effectiveness of programmatic advertising in a privacy-conscious environment.

Henry's Original is a producer of handcrafted cannabis products sourced from family-run farms in Mendocino County. Established in mid-2017, the company focuses on creating high-quality offerings for the health and wellness industry, including flower, pre-rolls, singles, and flower vape cartridges. Henry's Original emphasizes organic cultivation, ensuring its products meet and exceed California State standards. This commitment to quality has garnered attention from various media outlets, including the Los Angeles Times and Men's Journal, highlighting its dedication to providing consumers with premium, sustainably-grown cannabis directly from the farm.

GrowGeneration is a private company that specializes in the operation of hydroponic and organic gardening retail stores. The company focuses on capitalizing on the growing demand for home gardening and the legalization of marijuana. It serves as a marketer and distributor of a wide range of products essential for hydroponic gardening, including nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems, and various accessories. GrowGeneration operates through two main segments: the Cultivation and Gardening segment, which encompasses its hydroponic and organic gardening business, and the Storage Solutions segment, which includes its offerings in benching, racking, and storage solutions.

Vitruvias Therapeutics is a start-up generic pharmaceutical company based in Montgomery, Alabama, founded in 2013. The company specializes in developing niche topical generic products that are available only by prescription. Focusing on complex active pharmaceutical ingredients (APIs) and challenging finished dosage forms, Vitruvias Therapeutics aims to address the difficulties associated with manufacturing these products. By leveraging strategic partnerships, the company seeks to overcome manufacturing complexities and raw material sourcing challenges, thereby enhancing the availability of essential generic medications. The name Vitruvias is inspired by Leonardo da Vinci’s "Vitruvian Man," symbolizing the ideal proportions of the human figure, reflecting the company's commitment to precision in pharmaceutical development.

TerrAscend Corp. is a Canadian cannabis company that cultivates, processes, and sells medical and adult-use cannabis in Canada, the United States, and Europe. Founded in 2017 and headquartered in Mississauga, the company operates through subsidiaries that provide physician consultations, patient education, and support programs. It focuses on developing quality products that address the needs of patients, including prescription cannabinoids and medical cannabis solutions for those suffering from chronic pain and debilitating illnesses. Additionally, TerrAscend manufactures cannabis-infused artisan edibles and distributes hemp-derived wellness products to retail locations, while also operating retail dispensaries in California and Pennsylvania. The company is dedicated to drug research and development, as well as the advancement of cannabis delivery systems and health products.

Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, that specializes in developing a diverse portfolio of generic prescription products across various dosage forms and therapeutic categories. Founded in 2011, the company is focused on co-developing these products through strategic partnerships both domestically and internationally. Vensun has filed multiple Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. The company is also pursuing additional opportunities for partnerships, strategic alliances, and product acquisitions to further enhance its development portfolio, aiming to provide enhanced pharmaceuticals to clinicians and healthcare professionals in the U.S. generic market.

Establishment Labs S.A. is a medical technology company based in Alajuela, Costa Rica, that specializes in the design, development, manufacturing, and marketing of silicone-filled breast and body shaping implants. The company's flagship product line, Motiva Implants, features a variety of options in surface, shape, size, base, and projection and is sold in over 60 countries. Establishment Labs also offers innovative solutions such as the MotivaImagine application, which aids in surgical planning, and Q Inside Safety Technology, a radio frequency identification transponder that provides surgeons with implant-specific data. Additionally, the company provides Puregraft technology for purified fat reinjection and operates a center for breast augmentation consultations. Its manufacturing facilities comply with FDA and ISO standards, and the company has regulatory offices in the United States and a distribution center in Belgium. Established in 2004, Establishment Labs serves plastic surgeons and patients globally, emphasizing innovation in its product offerings.

Establishment Labs S.A. is a medical technology company based in Alajuela, Costa Rica, that specializes in the design, development, manufacturing, and marketing of silicone-filled breast and body shaping implants. The company's flagship product line, Motiva Implants, features a variety of options in surface, shape, size, base, and projection and is sold in over 60 countries. Establishment Labs also offers innovative solutions such as the MotivaImagine application, which aids in surgical planning, and Q Inside Safety Technology, a radio frequency identification transponder that provides surgeons with implant-specific data. Additionally, the company provides Puregraft technology for purified fat reinjection and operates a center for breast augmentation consultations. Its manufacturing facilities comply with FDA and ISO standards, and the company has regulatory offices in the United States and a distribution center in Belgium. Established in 2004, Establishment Labs serves plastic surgeons and patients globally, emphasizing innovation in its product offerings.

Aralez Pharmaceuticals is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of products primarily in cardiovascular care, pain management, and other specialized areas. The company offers a range of key products such as Fiorinal, Proferrin, Fibricor, Uracyst, Neovisc, and Cambia. Aralez operates primarily in the United States and Canada, with the majority of its revenue generated from the U.S. market. By serving customers worldwide, Aralez Pharmaceuticals aims to address significant medical needs through its targeted therapeutic offerings.

Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, that specializes in developing a diverse portfolio of generic prescription products across various dosage forms and therapeutic categories. Founded in 2011, the company is focused on co-developing these products through strategic partnerships both domestically and internationally. Vensun has filed multiple Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. The company is also pursuing additional opportunities for partnerships, strategic alliances, and product acquisitions to further enhance its development portfolio, aiming to provide enhanced pharmaceuticals to clinicians and healthcare professionals in the U.S. generic market.

Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, that specializes in developing a diverse portfolio of generic prescription products across various dosage forms and therapeutic categories. Founded in 2011, the company is focused on co-developing these products through strategic partnerships both domestically and internationally. Vensun has filed multiple Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. The company is also pursuing additional opportunities for partnerships, strategic alliances, and product acquisitions to further enhance its development portfolio, aiming to provide enhanced pharmaceuticals to clinicians and healthcare professionals in the U.S. generic market.

Arbor Pharmaceuticals is a specialty pharmaceutical company based in Raleigh, North Carolina, founded in 2006. It primarily focuses on pediatric medicine, licensing, developing, and commercializing late-stage products designed for common pediatric conditions. The company offers a range of products, including ZINOTIC and ZINOTIC ES for treating Acute Otitis Externa, NEOTIC for pain and inflammation associated with Acute Otitis Media, and XYLAREX for dietary management of Recurrent Acute Otitis Media. Additionally, Arbor Pharmaceuticals provides the Pediaderm HC Complete Kit, specifically formulated to treat and protect the skin of children with atopic dermatitis, commonly known as eczema. The company markets its products through specialized sales forces across the United States, while also engaging in research and development in therapeutic areas like cardiology, neurology, and endocrinology.